IncFact
Company Profiles: Revenue, Growth, Competition

ImmunoCellular Therapeutics Revenue, Growth & Competitor Profile

Last updated:

Company Awards

 
Public Company
public company
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for ImmunoCellular Therapeutics

Access the complete profile.

ImmunoCellular Therapeutics Fast Facts

RevenueLess than $1 million    See Exact Annual Revenue
EmployeesN/AExact Company Size
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes541214 Payroll Services
Address30721 Russell Ranch Road
Westlake Village, CA 91362

Note: Revenues for privately held companies are statistical evaluations.


ImmunoCellular Therapeutics's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • ImmunoCellular Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

ImmunoCellular Therapeutics Annual Revenue and Growth Rate

ImmunoCellular Therapeutics Revenue Est.
($ Million)
Growth Rate (%)# Employees
2025 Less than $1 million

Details in Premium Report
2024
2023
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: ImmunoCellular Therapeutics's revenues are gauged from an analysis of company filings.



ImmunoCellular Therapeutics's Income Statement (based on Industry Averages)

ImmunoCellular Therapeutics P&L$ Millions
Revenue (Sales) ImmunoCellular Therapeutics Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Investor Activity

ImmunoCellular Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
September 12, 2022 1 15%$5 MM
Complete list of funding rounds and total amounts in the Company Report




Market Share of ImmunoCellular Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as ImmunoCellular Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
LEIDOSDenver, CO100 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM30 
INC RESEARCHRaleigh, NC27 
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORKAlbany, NY17 
FLUOR MARINE PROPULSIONWest Mifflin, PA15 
SYNEOS HEALTHRaleigh, NC13 
ILLUMINASan Diego, CA12 
UT-BATTELLEOak Ridge, TN11 
PRA HOLDINGSRaleigh, NC11 




Nearby Competitors

These companies are similar in business line and location to ImmunoCellular Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
MANNKINDWestlake Village, CA100 
ARETE ASSOCIATESNorthridge, CA95 
BIONESSValencia, CA31 
BEREN THERAPEUTICS P.B.C.Newbury Park, CA28 
CHIME INSTITUTEWoodland Hills, CA22 
SETPOINT MEDICALValencia, CA21 




Other Companies at 30721 Russell Ranch Road, Westlake Village CA

Company HeadquartersRevenue ($ MM)
IPAYMENTWestlake Village, CA0 
STUDY SMART TUTORSWestlake Village Ca, CA0 


(0.0338 s)



Future Competition: ImmunoCellular Therapeutics's Fastest Growing Competitors

These companies are in the same general field as ImmunoCellular Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
ImmunoCellular Therapeutics Competitors